Canada vs Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand): Proportion of the target population who received the final dose of
Canada
86.0%
in 2024
Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand)
44.0%
in 2024
Canada rank
18th
Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand) rank
17th
Proportion of the target population who received the final dose of over time
- Canada
- Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand)
How they compare
Canada currently reports 86.0% against 44.0% in Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand), a difference of 42.0%.
That makes Canada's figure about 2.0 times Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand)'s.
Across all 12 years both countries report, Canada has been ahead every year.
Canada ranks 18th and Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand) ranks 17th of 107 countries.
Canada has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Canada | Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand) | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 78.6% | 33.0% | 45.6% | Canada |
| 2020s | 86.4% | 41.4% | 45.0% | Canada |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received the final dose of, Canada or Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand)?
- Canada, at 86.0% against 44.0% in Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand) as of 2024.
- What is the difference in proportion of the target population who received the final dose of between Canada and Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand)?
- 42.0%, with Canada ahead.
- How many years of comparable data are there for Canada and Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand)?
- 12 years are reported by both, from 2013 to 2024.
- How do Canada and Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand) rank globally for proportion of the target population who received the final dose of?
- Canada ranks 18th and Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand) ranks 17th of 107 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received the final dose of human papillomavirus (HPV) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.